SEC Form 4/A · accession 0001209191-16-154390
MARRONE BIO INNOVATIONS INC · MBII
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
James Boyd
Officer — Chief Financial Officer
Period of report
Aug 11, 2016
Accepted (ET)
Dec 9, 2016 · 4:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001441693
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 11, 2016 | A | 31,250 | $0.00 | A | 41,250 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The amount of securities beneficially owned following the reported transaction was incorrectly listed on the reporting person's Form 4 filed on August 11, 2016.